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Abstract C-CAM is a ubiquitously expressed cell adhesion
molecule belonging to the carcinoembryonic antigen family. Two
co-expressed isoforms, C-CAM-L and C-CAM-S, are known,
having different cytoplasmic domains both of which can be
phosphorylated in vivo. Here we have characterized the PKC-
mediated phosphorylation of the short cytoplasmic domain
isoform, C-CAM-S. Phorbol myristyl acetate induced phospho-
rylation of C-CAM-S in transfected CHO cells. Using synthetic
peptides and Edman degradation we identified Ser449 as the
PKC-phosphorylated amino acid residue. Binding experiments
with modified peptides indicated that this phosphorylation
decreases the ability of the cytoplasmic domain of C-CAM-S
to bind calmodulin.
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1. Introduction
Members of the immunoglobulin superfamily [1] participate
in cellular interactions and signaling processes necessary for
the organization, structural integrity and functions of cells
and tissues in multicellular organisms [2]. One of these mole-
cules, C-CAM, is a transmembrane cell adhesion molecule,
that is widely expressed in epithelia, vessel endothelia and
hematopoietic cells [3,4]. C-CAM was ¢rst noted for its ability
to mediate Ca2-independent cell adhesion in rat hepatocytes
[5], where it appears as two major isoforms, C-CAM-L (C-
CAM1) and C-CAM-S (C-CAM2) [3]. Due to di¡erential
splicing the cytoplasmic domain of C-CAM-L is larger (71^
73 amino acids) than that of C-CAM-S (10^12 amino acids).
While both C-CAM-L and C-CAM-S can mediate cell adhe-
sion [6], several other functions have also been attributed to
these molecules, especially to the larger isoform. C-CAM-L in
rats has been described as a bile salt transporter, an ecto-
ATPase, and a suppressor of tumor formation by prostate,
bladder and breast carcinoma cells [3,7^9]. Also the mouse
homologue of C-CAM-L, Bgp1, has been shown to suppress
tumor growth of colon carcinoma cells in syngeneic mice [10].
Furthermore, murine C-CAM is the receptor for mouse hep-
atitis virus [11].
Cell adhesion molecules can be regulated in several di¡erent
ways, which include both variations in expression levels, in-
teractions with other membrane and cytoplasmic proteins,
and covalent modi¢cations [2,12]. C-CAM seems to be regu-
lated by all of these mechanisms. During embryonic develop-
ment the expression of C-CAM varies in a characteristic spa-
tiotemporal pattern, and activation of di¡erent classes of
leukocytes leads to altered surface expression patterns of C-
CAM [3]. Protein tyrosine kinases and protein tyrosine phos-
phatases can bind to the cytoplasmic domain of C-CAM-L
[3,13,14], suggesting important functions in signal induction
and signal regulation. Of particular importance for the regu-
lation of C-CAM activities is the ¢nding that calmodulin can
bind to the cytoplasmic domains of both C-CAM-L and C-
CAM-S in a calcium-regulated manner, resulting in altered C-
CAM self-association and dimerization [15,16]. Another fea-
ture important for regulation of C-CAM is that both C-
CAM-L and C-CAM-S can be phosphorylated in vivo
[13,17^20]. C-CAM-L, that has a larger cytoplasmic domain
with more potential phosphorylation sites, has been shown to
be phosphorylated to a greater extent than C-CAM-S.
Most attention has been focused on the cytoplasmic domain
of C-CAM-L, which can be phosphorylated in vivo by both
protein kinase C (PKC) and tyrosine kinases [13,18,19] on
Ser503 and Tyr488, respectively. The e¡ects of phosphorylation
on the activities of C-CAM-L are not well understood, but
phosphorylation of Ser503 and Tyr488 appears to participate in
the regulation of transmembrane bile salt transport [18]. Ty-
rosine phosphorylation of C-CAM-L does not, however, seem
to a¡ect its cell adhesion activity [20]. Less is known about the
phosphorylation of C-CAM-S, that lacks phosphorylatable
tyrosine residues. Therefore we investigated the serine/threo-
nine phosphorylation pattern of this isoform. We report that
C-CAM-S can be phosphorylated on a speci¢c membrane-
proximal serine residue by PKC, and present data indicating
that PKC-mediated phosphorylation of this isoform alters its
potential to bind calmodulin.
2. Materials and methods
2.1. Peptide synthesis
Peptides were synthesized on cellulose membranes using the SPOT-
system (Cambridge Research Biochemical, Northwich, England)
[21,22] as previously described [15]. For peptides that were to be
sequenced, the acetylation step was omitted.
2.2. Phosphorylation of synthetic peptides
Phosphorylation of synthetic peptides was performed with protein
kinase C (PKC) as previously described [23]. PKC-L was prepared
from pig spleen, as described by Ferrari et al. [24]. The kinase speci¢c
activity was 300 U/mg; one unit was de¢ned as the amount of enzyme
that transferred 1 nmol of phosphate from ATP to histone (H1) in
one minute (1 mg histone H1/ml incubation bu¡er).
2.3. Amino acid sequence determination
Manual Edman degradation of the phosphorylated membrane-
bound peptides was performed as described by Sullivan and Wong
[25], with a few modi¢cations. Before sequencing, the peptide-contain-
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ing membranes were incubated in tri£uoroacetic acid (TFA) at 50‡C
for 10 min and were then washed with methanol and dried. For each
degradation cycle each membrane-spot was incubated at 50‡C for 10
min, in 0.5 ml of coupling solution (methanol:water:triethylamine:
phenylisothiocyanate; 7:1:1:1, v/v). The coupling solution was re-
moved, and the membranes were washed ¢ve times in methanol and
dried. The membranes were incubated at 50‡C for 5 min, in 0.5 ml of
TFA, and then again at room temperature for 1 min, in 1 ml of TFA:
42.5% H3PO4 (9:1, v/v). Finally, the membranes were washed with
methanol, dried and subjected to a new degradation cycle. The two
TFA wash solutions from each degradation cycle were combined and
analyzed for 32P-activity. Also the remaining peptide-bound 32P-activ-
ity was measured after each degradation cycle. 32P-activity was deter-
mined as Cerenkov radiation.
2.4. Calmodulin binding to synthetic peptides
Binding of 125I-labeled calmodulin to membrane-bound synthetic
peptides was determined as previously described [15].
2.5. Phosphorylation of cellular C-CAM
C-CAM-S-transfected CHO Pro5 cells (American Tissue Culture
Collection) [6] were seeded in 60 mm tissue culture dishes (1U106
cells per dish) on day 1, and cultured overnight. On day 2 the cells
(2U106 cells per dish) were washed in phosphate-free MEM medium
(Gibco BRL), and incubated in 2 ml phosphate-free MEM, 8% fetal
calf serum and 1 mCi [32P]orthophosphate (NEN) for 4 h at 37‡C.
Phorbol myristyl acetate (PMA) was added to some dishes to a ¢nal
concentration of 20 nM, and the cells were incubated for another
15 min. The medium was then removed, the cells were washed with
0.15 M NaCl, 10 mM Tris-HCl, pH 7.4, and lysed for 60 min at 4‡C
in 0.5 ml of 1% Triton X-100, 0.15 M NaCl, 5 mM EDTA, 2 mM
sodium £uoride, 2 mM sodium pyrophosphate, 2 mg/ml aprotinin,
5 mg/ml leupeptin, 0.4 mg/ml pepstatin, 200 mg/ml (4-amidinophen-
yl)-methanesulfonyl£uoride (APMSF), 10 mM Tris-HCl, pH 7.4. The
lysate was centrifuged in an Eppendorf centrifuge, and the super-
natant was precipitated with anti-C-CAM antiserum (anti-C-
CAM10 in [4]) or preimmune immunoglobulins, after pretreatment
with preimmune serum. The immunoprecipitates were then analyzed
by SDS-PAGE, followed by both autoradiography and immunoblot-
ting with anti-C-CAM antibodies and alkaline phosphatase-conju-
gated secondary antibodies.
3. Results and discussion
The phosphorylation sites in C-CAM-S have not, until
now, been identi¢ed. In all C-CAM expressing cells analyzed
so far, C-CAM-L and C-CAM-S are co-expressed [26], a fact
which complicates a detailed biochemical analysis, as the two
isoforms are di⁄cult to separate. In this investigation we
therefore analyzed transfected CHO cells expressing only the
C-CAM-S isoform. Since the cytoplasmic domains of both C-
CAM-S and C-CAM-L contain putative phosphorylation sites
for PKC (Fig. 1) [27] we investigated if PKC can phospho-
rylate C-CAM-S in vivo by incubating the cells with radio-
active orthophosphate and the PKC-stimulatory drug PMA.
The cells were lysed and the lysates were immunoprecipitated
and analyzed by SDS-PAGE and autoradiography. No 32P-
labeled proteins were speci¢cally immunoprecipitated in C-
CAM-S-transfected, unstimulated cells (Fig. 2, lanes A and
C), but C-CAM-S became strongly phosphorylated in the
PMA-stimulated cells (Fig. 2, lane B). Control immunoglobu-
lins did not recognize any phosphorylated proteins in PMA-
stimulated cells (Fig. 2, lane D). Thus, activated PKC seems
to phosphorylate the cytoplasmic domain of C-CAM-S in
vivo.
In order to identify the amino acids that were phosphoryl-
ated by PKC, we used puri¢ed PKC-L for phosphorylation of
synthetic decapeptides corresponding to di¡erent regions of
the cytoplasmic domains of C-CAM. The peptides were syn-
thesized on cellulose membranes; such peptides have recently
been reported to be good substrates for protein kinases with-
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Fig. 1. Amino acid sequences and potential phosphorylation sites of C-CAM-L and C-CAM-S cytoplasmic domains. The amino acid sequences
of the cytoplasmic domains of C-CAM-L and C-CAM-S of rat, mouse and human origin, are shown in single letter code. The two most N-ter-
minal amino acids (shown to the left in bold and italic font) are believed to be members of the transmembrane region. The most N-terminal
serine residue shown in the rat and mouse sequences is S449. Sequence requirements for potential PKC phosphorylation sites, according to Ken-
nelly and Krebs [27], are indicated in the inset. Potential PKC-phosphorylatable serine and threonine residues in the C-CAM sequences are
underlined. The C-CAM-L tyrosine residue (Y488), shown to be phosphorylated in vivo, is also underlined.
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out steric hindrance of enzyme access to the most C-terminal
amino acids [23,28]. The phosphorylated peptides were sub-
jected to manual Edman degradation and the amounts of
released and remaining [32P]phosphate were determined after
each degradation cycle (Fig. 3A). Analysis of two di¡erent
decapeptides, staggered by two amino acids, revealed that
PKC primarily phosphorylated the serine residue at position
449 in peptides corresponding to the C-CAM-S sequence (Fig.
3B). PKC requires positively charged arginine and/or lysine
residues in the vicinity of the phosphorylatable serine or
threonine residues for optimal activity (Fig. 1) [27]. In order
to analyze the speci¢city of the PKC-catalyzed phosphoryla-
tion we therefore synthesized peptides in which the arginine
and lysine residues (Arg450 and Lys451) in the C-CAM-S cy-
toplasmic domain were replaced with alanine residues. These
peptides showed drastically lower phosphorylation levels (data
not shown), demonstrating that the phosphorylation of Ser449
is in agreement with the known speci¢city of PKC. Because
the membrane-proximal region of the cytoplasmic domain of
C-CAM-L is similar in sequence to that of C-CAM-S (Fig. 1),
we also phosphorylated synthetic peptides with C-CAM-L
sequences and found that the corresponding serine residue
(Ser449) in C-CAM-L could also be speci¢cally phosphoryl-
ated by PKC (data not shown).
The speci¢c phosphorylation of one serine residue in the
cytoplasmic domain of C-CAM-S by PKC suggests that
PKC-mediated phosphorylation may be important for regula-
tion of C-CAM-S function. While the cytoplasmic domain of
C-CAM-L can interact with several signaling molecules, the
cytoplasmic domain of C-CAM-S has so far only been found
to be able to bind calmodulin [15] ; in fact, calmodulin binding
is the only known activity of the C-CAM-S cytoplasmic do-
main. Therefore, we thought it to be of interest to investigate
if phosphorylation of C-CAM-S interferes with binding of
calmodulin.
We ¢rst measured calmodulin binding to synthetic peptides
that were phosphorylated in vitro by PKC. On average, PKC
phosphorylation decreased calmodulin binding to the pepti-
des, but the variation in the calmodulin binding levels between
experiments was too large to allow precise analysis of these
experiments. This variation was probably due to adsorption
of components in the PKC preparation to the peptide-con-
taining cellulose membranes, with subsequent in£uence on
calmodulin binding to the membranes. We therefore took an-
other approach, and synthesized peptides in which phospho-
rylation was simulated by replacing the serine and threonine
residues with negatively charged glutamic acid residues. Cal-
modulin binding decreased to 25% and 16%, respectively, fol-
lowing these substitutions at S449 in C-CAM-L and C-CAM-S
peptides (Table 1). When two or more serine/threonine resi-
dues were replaced by glutamic acid residues, calmodulin
binding was completely abolished. To verify that this decrease
in binding level was caused by the introduced negatively
charged residues and not by structural changes in the peptide
or the loss of a hydroxyl group at the position of the serine/
threonine residues, a large number of peptides were synthe-
sized, in which each amino acid residue systematically was
changed to an alanine residue. Strikingly, only when one or
both of the two basic residues (Arg450 and Lys451) were sub-
stituted, there was a signi¢cant change in calmodulin binding
(data not shown). Both the arginine and the lysine residues
are required for calmodulin binding [15]. Exchange of the
serine/threonine residues for alanine did not alter the level
of calmodulin binding. This is thus compatible with the idea
that phosphorylation of C-CAM at a speci¢c serine residue
can abolish calmodulin binding by the introduction of nega-
tive charges.
As C-CAM-S has been demonstrated to mediate cell-to-cell
adhesion of the transfected CHO cells it was of interest to see
if PKC-catalyzed phosphorylation would a¡ect its adhesive
function. We therefore investigated how PMA a¡ected the
aggregation of untransfected and C-CAM-S-transfected
CHO cells, and found that PMA stimulated aggregation to
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Table 1
Binding of calmodulin to C-CAM peptides
Peptide sequence % Binding
C-CAM-L LYSRKTGGGS 100
LYERKTGGGS 25
LYSRKEGGGS 25
LYSRKTGGGE 51
LYERKEGGGE 2
C-CAM-S SRKTGGSGSF 100
ERKTGGSGSF 16
SRKEGGSGSF 7
SRKTGGEGSF 13
SRKTGGSGEF 24
ERKEGGEGEF 2
Serine and threonine residues were replaced by glutamic acid in syn-
thetic C-CAM peptides, and binding of calmodulin to the peptides
was measured. The substituted glutamic acid residues are indicated by
a bold ‘E’. The level of calmodulin binding to each modi¢ed peptide is
given as a percentage of binding to the corresponding unmodi¢ed
peptide.
Fig. 2. PMA-stimulated phosphorylation of C-CAM-S in CHO cells.
Triton X-100 extracts from C-CAM-S-transfected CHO cells, incu-
bated with [32P]orthophosphate, were precipitated with anti-C-CAM
antibodies (A and B) or preimmune immunoglobulins (C and D).
The precipitated samples were analyzed by SDS-PAGE and auto-
radiography. The migration positions of molecular weight markers
are indicated: Untreated cells (A and C); PMA-treated cells (B and
D). The samples were also immunoblotted with anti-C-CAM anti-
bodies (shown below each lane).
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a large extent (data not shown). However, both the untrans-
fected and the transfected cells were stimulated to the same
extent, and detailed analysis using adhesion-blocking antibod-
ies against C-CAM revealed that PMA did not a¡ect the C-
CAM-S-mediated adhesion. Since calmodulin can bind to the
cytoplasmic domains of C-CAM when the calcium concentra-
tion is increased we also investigated if increasing the intra-
cellular calcium concentration by addition of calcium iono-
phores would a¡ect adhesion. A slight inhibitory e¡ect was
observed, but also in this case it could not be clearly distin-
guished from the e¡ects on untransfected cells. Therefore, we
conclude that neither phosphorylation nor calmodulin binding
in£uences the intercellular adhesive activity of C-CAM-S in
transfected CHO cells.
Since PKC-mediated phosphorylation of C-CAM-S does
not appear to in£uence its basic adhesive activity, phospho-
rylation of C-CAM-S probably has other regulatory e¡ects.
One possibility is that it might in£uence interactions with
other molecules, as demonstrated for calmodulin. Phospho-
rylation might also a¡ect the supramolecular organization of
C-CAM. It has been demonstrated that both C-CAM-L and
C-CAM-S can form homodimers in the plane of the mem-
brane in epithelial cells [16]. C-CAM dimer formation can
be regulated by the cells, and the extent of dimers varies
between di¡erent cell types. Calmodulin seems to be one fac-
tor that can regulate C-CAM dimers, as binding of calmodu-
lin leads to dimer dissociation [16]. Accordingly, phosphoryl-
ation of the cytoplasmic domain of C-CAM-S might be
important for regulating C-CAM dimerization, both by inter-
fering with calmodulin binding and perhaps by directly in£u-
encing the a⁄nity between C-CAM monomers. Regulation of
C-CAM dimerization might have important e¡ects on the
signal regulatory functions of C-CAM [3].
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